Full-Time

Professional Aesthetic Associate

Central Region

Posted on 4/30/2024

Revance

Revance

501-1,000 employees

Develops neuromodulator treatments for frown lines


Senior

Chicago, IL, USA

Required Skills
Sales
Marketing
Requirements
  • BS/BA Degree or equivalent
  • 3+ years account management experience
  • Documented track record of exceeding sales objectives
  • Consultative sales training
  • Ability to travel 75-90%
  • 2+ years in pharmaceutical, device, and/or healthcare industry
  • Experience in medical aesthetics, working in dermatology or plastic surgery
  • New product launch experience
  • Experience in buy and bill or cash pay medicine
  • Valid driver’s license
Responsibilities
  • Attain or exceed quarterly sales objectives and developmental objectives
  • Execute sales and marketing strategies
  • Build and nurture relationships with customers
  • Provide and filter key market insights back to sales and marketing management
  • Work effectively with teammates
  • Maintain a pipeline of opportunities to meet or exceed sales objectives
  • Perform sales calls with customers and potential customers as assigned
  • Maintain accurate reporting, records, and files
  • Positively represent Revance throughout customer locations
  • Actively participate in scheduled Company sales meetings, conference calls, and other necessary business meetings
  • Demonstrate honesty and integrity while modeling behaviors consistent with company standards and policies for business and compliance
  • Perform other duties as assigned

Revance specializes in a neuromodulator therapeutics pipeline featuring DaxibotulinumtoxinA for Injection, utilizing acetylcholine release inhibition and neuromuscular blocking agents to temporarily improve moderate to severe glabellar lines in adults. The product uses peptide-powered technology to provide long-lasting treatment for frown lines.

Company Stage

IPO

Total Funding

$1.8B

Headquarters

Nashville, Tennessee

Founded

1999

Growth & Insights
Headcount

6 month growth

-7%

1 year growth

-1%

2 year growth

16%
INACTIVE